Abstract
The tumor vasculature is a chaotic mixture of abnormal, hierarchically disorganized vessels that differ from those of normal tissues with respect to organization, structure and function. Firstly, tumor vessel wall structure is abnormal and heterogeneous within the tumor. Besides contractile wall components, the perivascular compartment is often lacking pericytes, what makes the tumor vessels fragile and leaky. Secondly, another group of abnormalities involves distortions in angioarchitecture and vasculature as network. Common features of tumor vessels, irrespective of their origin, size and growth pattern, are absence of hierarchical organization, formation of vessels with irregular contours and their heterogeneous distribution within the tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298–307. doi:10.1038/nature10144
Kraljevic S, Stambrook PJ, Pavelic K (2004) Accelerating drug discovery. EMBO Rep 5(9):837–842. doi:10.1038/sj.embor.7400236
Singh M, Ferrara N (2012) Modeling and predicting clinical efficacy for drugs targeting the tumor milieu. Nat Biotechnol 30(7):648–657. doi:10.1038/nbt.2286
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353–364
Gaustad JV, Simonsen TG, Leinaas MN, Rofstad EK (2012) Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts. BMC Cancer 12:388. doi:10.1186/1471-2407-12-388
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257. doi:10.1038/35025220
Warren BA (1979) The vascular morphology of tumors. In: Peterson H-I (ed) Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. CRC Press Inc., Boca Raton, FL, pp 1–47
Nagy JA, Chang SH, Shih SC, Dvorak AM, Dvorak HF (2010) Heterogeneity of the tumor vasculature. Semin Thromb Hemost 36(3):321–331. doi:10.1055/s-0030-1253454
Hlushchuk R, Riesterer O, Baum O, Wood J, Gruber G, Pruschy M, Djonov V (2008) Tumor recovery by angiogenic switch from sprouting to intussusceptive angiogenesis after treatment with PTK787/ZK222584 or ionizing radiation. Am J Pathol 173(4):1173–1185. doi:10.2353/ajpath.2008.071131
Dvorak HF (2003) Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma. Am J Pathol 162(6):1747–1757
Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe’er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155(3):739–752. doi:10.1016/S0002-9440(10)65173-5
Stubbs M, McSheehy PM, Griffiths JR, Bashford CL (2000) Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6(1):15–19
Kimbrough CW, Khanal A, Zeiderman M, Khanal BR, Burton NC, McMasters KM, Vickers SM, Grizzle WE, McNally LR (2015) Targeting acidity in pancreatic adenocarcinoma: multispectral optoacoustic tomography detects pH-low insertion peptide probes in vivo. Clin Cancer Res 21(20):4576–4585. doi:10.1158/1078-0432.CCR-15-0314
Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7(8):345–350
Burri PH, Hlushchuk R, Djonov V (2004) Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev Dyn 231(3):474–488. doi:10.1002/dvdy.20184
van Hinsbergh VW, Koolwijk P (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78(2):203–212. doi:10.1093/cvr/cvm102
Hlushchuk R, Makanya AN, Djonov V (2011) Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again? Int J Dev Biol 55(4–5):563–567. doi:10.1387/ijdb.103231rh
Carmeliet P, De Smet F, Loges S, Mazzone M (2009) Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way. Nat Rev Clin Oncol 6(6):315–326. doi:10.1038/nrclinonc.2009.64
Dome B, Hendrix MJ, Paku S, Tovari J, Timar J (2007) Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. Am J Pathol 170(1):1–15. doi:10.2353/ajpath.2007.060302
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182–1186. doi:10.1056/NEJM197111182852108
Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58–62. doi:10.1126/science.1104819
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O’Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):966–978. doi:10.1043/0003-9985(2000)124<0966:PFIBC>2.0.CO;2
Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M, Belien JA, de Waal RM, Van Marck E, Magnani E, Weidner N, Harris AL, Dirix LY (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38(12):1564–1579
Elagoz S, Egilmez R, Koyuncu A, Muslehiddinoglu A, Arici S (2006) The intratumoral microvessel density and expression of bFGF and nm23-H1 in colorectal cancer. Pathol Oncol Res 12(1):21–27, doi:PAOR.2006.12.1.0021
Marson LP, Kurian KM, Miller WR, Dixon JM (1999) Reproducibility of microvessel counts in breast cancer specimens. Br J Cancer 81(6):1088–1093. doi:10.1038/sj.bjc.6690811
Fox SB, Leek RD, Weekes MP, Whitehouse RM, Gatter KC, Harris AL (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count, and computer image analysis. J Pathol 177(3):275–283. doi:10.1002/path.1711770310
Ehling J, Bartneck M, Wei X, Gremse F, Fech V, Möckel D, Baeck C, Hittatiya K, Eulberg D, Luedde T (2014) CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis. Gut 63(12):1960–1971
Kiessling F, Greschus S, Lichy MP, Bock M, Fink C, Vosseler S, Moll J, Mueller MM, Fusenig NE, Traupe H (2004) Volumetric computed tomography (VCT): a new technology for noninvasive, high-resolution monitoring of tumor angiogenesis. Nat Med 10(10):1133–1138
Gremse F, Grouls C, Palmowski M, Lammers T, de Vries A, Grüll H, Das M, Mühlenbruch G, Akhtar S, Schober A (2011) Virtual elastic sphere processing enables reproducible quantification of vessel stenosis at CT and MR angiography. Radiology 260(3):709–717
Schambach SJ, Bag S, Steil V, Isaza C, Schilling L, Groden C, Brockmann MA (2009) Ultrafast high-resolution in vivo volume-CTA of mice cerebral vessels. Stroke 40(4):1444–1450
Figueiredo G, Brockmann C, Boll H, Heilmann M, Schambach SJ, Fiebig T, Kramer M, Groden C, Brockmann MA (2012) Comparison of digital subtraction angiography, micro-computed tomography angiography and magnetic resonance angiography in the assessment of the cerebrovascular system in live mice. Clin Neuroradiol 22(1):21–28
Sawall S, Kuntz J, Socher M, Knaup M, Hess A, Bartling S, Kachelrieß M (2012) Imaging of cardiac perfusion of free-breathing small animals using dynamic phase-correlated micro-CT. Med Phys 39(12):7499–7506
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Hlushchuk, R., Barré, S., Djonov, V. (2016). Morphological Aspects of Tumor Angiogenesis. In: Ribatti, D. (eds) Tumor Angiogenesis Assays. Methods in Molecular Biology, vol 1464. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3999-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3999-2_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3997-8
Online ISBN: 978-1-4939-3999-2
eBook Packages: Springer Protocols